Site-selective, PDE-resistant and membrane-permeant activator of cAMP-dependent protein kinase. Sp-6-Bnz-cAMPS does not activate Epac and thus can be used as an Epac-negative control. For more details on site selectivity please inquire. Detailed technical information available. Reference: Lim et al., Neurosci. Lett., 479, 13 - 17 (2010).
Cat. No. | B 040 |
CAS number | [152218-18-3] |
Purity | > 98% HPLC |
Salt form | Sodium |
Storage temperature | -20°C / -4°F |
Molecular formula | C₁₇H₁₅N₅O₆PS · Na |
Molecular weight [g/mol] | 471.4 |
cAMP modified at the exocyclic oxygen | axial (Sp-) |
Target | PKA (cAK) Activator |
Lipophilicity | 2.15 |
Absorption max [nm] | 279 |
Molar extinction coefficient ε [L·mol⁻¹·cm⁻¹] | 17000 |